Up to three in every 10 Chinese adults experienced long Covid symptoms in a survey of more than 70,000 residents, offering rare insight into the scale of lingering issues plaguing the country’s 1.4 ...
The IND approval received from the FDA on the GLORIA study protocol is a major step forward in the deployment of PHAXIAM's international clinical strategy. The company has already identified 5 ...